Document is current
Any future updates will be listed below
-
Authors
Brumfiel, Caitlin M.
Patel, Meera H. http://orcid.org/0000-0001-8174-0382
Puri, Pranav
Besch-Stokes, Jake
Lester, Scott
Rule, William G.
Khera, Nandita
Sluzevich, Jason C.
DiCaudo, David J.
Comfere, Nneka
Bennani, N. Nora
Rosenthal, Allison C.
Pittelkow, Mark R.
Mangold, Aaron R.
- License Information
-
More Information
Article History
Accepted: 13 May 2021
First Online: 27 September 2021
Declarations
:
: Caitlin M. Brumfiel declares that she has no conflict of interest. Meera H. Patel declares that she has no conflict of interest. Pranav Puri declares that he has no conflict of interest. Jake Besch-Stokes declares that he has no conflict of interest. Scott Lester declares that he has no conflict of interest. William G. Rule declares that he has no conflict of interest. Nandita Khera declares that she has no conflict of interest. Jason C. Sluzevich declares that he has no conflict of interest. David J. DiCaudo declares that he has no conflict of interest. Nneka Comfere declares that she has no conflict of interest. N. Nora Bennani currently serves on advisory boards for Verastem Oncology, Acrotech Biopharma, Kyowa Kirin, and Daiichi-Sankyo. Allison C. Rosenthal declares that she has no conflict of interest. Mark R. Pittelkow declares that he has no conflict of interest. Aaron R. Mangold has received institutional research funding from Kyowa Kirin, Miragen Therapeutics, Regeneron Pharmaceuticals, Corbus Pharmaceuticals, Sun Pharmaceutical Industries, Incyte, Pfizer, Eli Lilly, Elorac Pharmaceuticals, Novartis, Janssen, Soligenix, the American Society for Dermatologic Surgery, and the Dermatology Foundation; has received compensation for service as a consultant from Kyowa Kirin, Eli Lilly, Momenta Pharmaceuticals, UCB, Regeneron Pharmaceuticals, Genentech, and PHELEC.
